Janux Therapeutics Current Deferred Revenue (Quarterly) Analysis

Janux Therapeutics, Inc. (JANX)

14.82 -0.32 (-2.15%) USD | NASDAQ | Jan 23, 16:00

14.69 -0.12 (-0.84%) After-Hours: 20:00

View Current Deferred Revenue (Quarterly) for JANX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Bristol Myers Squibb Co.	--
Eli Lilly & Co.	--
Ionis Pharmaceuticals, Inc.	Upgrade
MannKind Corp.	Upgrade
Madrigal Pharmaceuticals, Inc.	--